Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Opthea Ltd ADR (NQ: OPT ) 4.990 -0.040 (-0.80%) Streaming Delayed Price Updated: 3:59 PM EDT, Oct 18, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 5,135 Open 5.070 Bid (Size) 4.950 (2) Ask (Size) 5.190 (1) Prev. Close 5.030 Today's Range 4.980 - 5.150 52wk Range 1.600 - 5.450 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News 12 Health Care Stocks Moving In Tuesday's Intraday Session October 01, 2024 Via Benzinga Darden Restaurants Posts Q1 Results, Joins Tesla, Nvidia, XPeng And Other Big Stocks Moving Higher On Thursday September 19, 2024 Via Benzinga Performance YTD +66.89% +66.89% 1 Month +29.27% +29.27% 3 Month +138.76% +138.76% 6 Month +47.63% +47.63% 1 Year +211.88% +211.88% More News Read More 12 Health Care Stocks Moving In Friday's Pre-Market Session June 14, 2024 Via Benzinga 7 Growth Stocks to Buy to Outperform the Nasdaq Index April 03, 2024 Via InvestorPlace Why Netflix Shares Are Trading Higher By 10%; Here Are 20 Stocks Moving Premarket January 24, 2024 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday January 24, 2024 Via InvestorPlace Why Is Retinal Diseases-Focused Opthea Stock Trading Higher Today? December 27, 2023 Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session December 27, 2023 Via Benzinga Opthea to Receive US$35M Commitment and Additional US$50M Funding December 27, 2023 From Opthea Limited Via GlobeNewswire Opthea Receives A$8.8 million R&D Tax Incentive December 19, 2023 From Opthea Limited Via GlobeNewswire Opthea to Present at the FLORetina 2023 Congress December 01, 2023 From Opthea Limited Via GlobeNewswire Opthea to Present at the Jefferies 2023 London Healthcare Conference November 09, 2023 From Opthea Limited Via GlobeNewswire Opthea to Present at Eyecelerator Forum at the 2023 American Academy of Ophthalmology (AAO) Conference October 30, 2023 From Opthea Limited Via GlobeNewswire Opthea Appoints U.S.-Based Leadership with Fred Guerard as CEO and Peter Lang as CFO October 27, 2023 From Opthea Limited Via GlobeNewswire Opthea to Participate at the 2023 Euretina Congress October 02, 2023 From Opthea Limited Via GlobeNewswire Opthea to Present at the H.C. Wainwright 25th Annual Global Investment Conference September 07, 2023 From Opthea Limited Via GlobeNewswire Why NovoCure Are Trading Lower By Around 31%? Here Are Other Stocks Moving In Monday's Mid-Day Session August 28, 2023 Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session August 28, 2023 Via Benzinga Opthea Successfully Completes Institutional Offer and Increases Capital Raising to A$90.0m (US$57.6 million¹) August 28, 2023 From Opthea Limited Via GlobeNewswire Opthea Announces “Sozinibercept” as the Nonproprietary Drug Name for OPT-302 July 26, 2023 From Opthea Limited Via GlobeNewswire Opthea to Present at the 2023 Ophthalmology Innovation Summit July 24, 2023 From Opthea Limited Via GlobeNewswire Opthea to Feature at the American Society of Retina Specialists 2023 Annual Meeting July 13, 2023 From Opthea Limited Via GlobeNewswire Opthea Announces Departure of Chief Medical Officer and Appointment of Senior Medical Advisor July 10, 2023 From Opthea Limited Via GlobeNewswire Opthea Appoints Anshul Thakral as Non-Executive Director of the Board June 08, 2023 From Opthea Limited Via GlobeNewswire Opthea to Present at the Jefferies 2023 Healthcare Conference May 25, 2023 From Opthea Limited Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.